Additional file 2: of Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA Leihong Wu Taylor Ingle Zhichao Liu Anna Zhao-Wong Stephen Harris Shraddha Thakkar Guangxu Zhou Junshuang Yang Joshua Xu Darshan Mehta Weigong Ge Weida Tong Hong Fang 10.6084/m9.figshare.7850462.v1 https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Study_of_serious_adverse_drug_reactions_using_FDA-approved_drug_labeling_and_MedDRA/7850462 Table S2. Drugs and PT distributions among MedDRA SOCs (XLS 33 kb) 2019-03-14 05:00:00 Adverse drug reactions Data mining MedDRA Drug labeling Boxed Warning Structured product labeling Standard terminology Drug safety